12/18
09:19 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
12/18
08:55 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
12/10
10:00 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
12/10
10:00 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
12/9
10:39 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
12/9
10:39 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
11/1
12:38 pm
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $55.00 price target on the stock.
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $55.00 price target on the stock.
11/1
12:38 pm
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $55.00 price target on the stock.
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $55.00 price target on the stock.
11/1
12:31 pm
agio
Rating for AGIO
Low
Report
Rating for AGIO
11/1
12:31 pm
agio
Rating for AGIO
Low
Report
Rating for AGIO
11/1
10:18 am
agio
Rating for AGIO
Low
Report
Rating for AGIO
11/1
10:18 am
agio
Rating for AGIO
Low
Report
Rating for AGIO
10/16
10:23 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
10/16
10:23 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
10/16
08:44 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
10/16
08:44 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
10/10
09:36 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $51.00 price target on the stock.
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $51.00 price target on the stock.
10/10
09:36 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $51.00 price target on the stock.
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $51.00 price target on the stock.
10/10
08:53 am
agio
Rating for AGIO
Low
Report
Rating for AGIO
10/10
08:53 am
agio
Rating for AGIO
Low
Report
Rating for AGIO
9/27
07:41 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $56.00 price target on the stock, down previously from $60.00.
Medium
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $56.00 price target on the stock, down previously from $60.00.
9/27
07:27 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO